+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

After spending lots of time and efforts on clinical testing, these unique “living medicines” are finally poised to hop from the realm of clinical research to the world of mainstream medicine. To give these therapies their best chance of success, the cell and gene therapy industry needs to ensure that each step of the drug development and delivery process is as robust and cost-effective as possible.

The main challenges still lie in the manufacturing and delivery processes which needs to be closely examined for optimization opportunities to further maximize the chances for effectiveness in patients.

At the 3rd Annual Bioprocessing of Advanced Cellular Therapies Congress, scheduled from 29th - 30th May 2018, in Frankfurt, Germany, we aim to address these exact challenges from the manufacturing processes of cell and gene therapy to safety, quality, logistics and regulatory hurdles. We will also be discussing the implementation of automated, highly validated protocols and tools which can give these therapies the best chance of success.


Click here to view the post show report of the 2nd Annual Bioprocessing of Advanced Cellular Therapies Congress 2017. 

conference Registration Form

-


 
  
CategoryCost
Academic Delegate€399
Industry Delegate €499
Solution Provider Delegate€1199

Agenda

Key Sessions

  • Regulatory and Reimbursement
  • CAR-T & Cell Therapy Processing
  • Viral Vector & Gene Therapy Manufacturing
  • Analytics & Quality Control
  • Logistics & Up-scale Processes

For more information on the agenda of the conference, you can write to us at amit.shelke@marketsandmarkets.com

 

 

 

Who Should Attend ?

Industry Professionals

Engineers, scientists, academics and professionals working in 

  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Biotechnology
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Scale-up/out
  • Data management for cell-based products
  • Bioprocess development
  • Cellular Therapy
  • Gene Therapy
  • Therapeutics
  • Pharmacology
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs


Academia: Universities and Research Institute 

Scientists/Professors/Researchers/Project leaders in
  • Cell therapy
  • Gene therapy
  • Cell culture
  • Cell Engineering
  • Bioprocessing
  • Biochemistry
  • Bioengineering
  • Biomaterials
  • Chemical Engineering
  • Molecular Biology
  • Material Sciences
  • Pharmacology
  • Biotechnology

Advisory Panel

  • Manuel Carrondo
    Professor of Chemical and Biochemical Engineering, FCT-UNL, Vice-President
    Institute of Experimental Biology and Technology (iBET), Portugal

 

  • Stefano Baila
    Industrialization Manager
    Celyad, Brussels, Belgium

 

  • Tiffany Rau
    Head of Technical Operations (Process Development to Commercialization (Vial thaw to API) and Bioreactor Development)
    Evonik, San Fransisco, USA

 

  • Benoît Champluvier
    Chief Technology and Manufacturing Officer
    BONE THERAPEUTICS S.A, Brussels, Belgium

 

  • Peter Hollands
    Group Chief Scientific Officer and Executive Director
    WideCells Group PLC, UK

SPEAKERS

  • Bo Kara

    Head Process Development, Cell & Gene Therapy Platform CMC, GSK, United Kingdom

  • Matthew Durdy

    Chief Business officer, CT Catapult, United Kingdom

  • Mannuel Carrando

    Vice President, IBET, Portugal

  • Stefano Baila

    Holding F.I.S, Belgium

  • Shimon Slavin

    Professor of Medicine, Biotherapy International, Israel

  • Robert Thomas

    Professor of Manufacturing for Cell and Gene Therapies, Loughborough University, United Kingdom

  • Vicki Coutinho

    Director, Regulatory Affairs , Autolus Ltd., United Kingdom

  • Sarah Snykers

    QC Manager, Celyad, Belgium

  • Jef Pinxteren

    Director process development, Promethera, Belgium

  • Yuan Zhao

    Leader, Gene Therapy Section, NIBSC, United Kingdom

  • Lior Raviv

    VP Development ,Pluristem Therapeutics, Israel

  • Pierre Heimendinger

    Head of Pharmaceutical Development, TxCell, France

  • Lisa O'Flynn

    Head of Process Development, Orbsen Therapeutics, Ireland

  • Jean-Charles Epinat

    Chief Technological Officer, Cellectis, France

  • Klaus Cichutek

    President, Paul-Ehrlich-Institut, Germany

  • Giuliana Vallanti

    Development & Quality Control Director Molmed Italy

  • Otto Merten

    Head of the Applied Vectorology and Innovation group, Généthon, Paris
    

SPONSORS

Eppendorf

Eppendorf - We Know Bioprocessing

By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player and valuable resource to its customers. With an integrated portfolio comprising software, instruments, consumables, and services, we can satisfy the demands of bioprocess development through production. In that way and in line with our corporate mission, we contribute to the efforts of Eppendorf customers worldwide to improve human living conditions.

TrakCelTractel

TrakCel is the market leading designer, developer and deliverer of integrated technologies specifically created in 2012 to manage the international autologous and allogeneic cell, gene and immunotherapy supply chain. TrakCel's software platform has been developed in collaboration with, and increasingly adopted by leading companies in the cell, gene and immunotherapy industries. TrakCel’s solutions deliver real-time control over the entire therapeutic supply chain, from sample collection through manufacturing to treatment delivery. The TrakCel platform accelerates global scale-up and scale-out of cell and gene therapy products, increasing efficiency and decreasing complexity, while maintaining needle-to-needle compliance and traceability.  

Cellgenix

CellGenix

CellGenix is a premium supplier of high-quality GMP reagents and tools for cell and gene therapy and regenerative medicine applications. We offer a comprehensive product portfolio in combination with expert regulatory and technical support to ensure a seamless transition from research to commercialization. Our products combine a maximum of quality and safety due to state-of-the-art production, stringent in-house quality control and comprehensive documentation.


 

MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 

 
Exhibiting

All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation/workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-One Meetings

Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty-minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support

MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact us at events@marketsandmarkets.com

Media partners

SUPPORTING ASSOCIATIONS

RegmedNet

RegMedNet

RegMedNet is a community site that unites the diverse regenerative medicine community. Through partnership with our sister journal, Regenerative Medicine, we seek to educate and inspire to help this exciting field move forward at an even faster rate. On RegMedNet, you can find free educational webinars, expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances. Every step in the regenerative medicine and cell therapy pipeline is covered on RegMedNet, from development, clinical trial and manufacture to regulation and commercialization. RegMedNet members have the opportunity to connect and collaborate with industry leaders and academic experts as well as publish their own articles without the wait. 


The United Kingdom Society for Biomaterials (UKSB)United Kingdom Society for Biomaterials (UKSB)

The United Kingdom Society for Biomaterials (UKSB) was set up to serve the diverse, interdisciplinary biomaterials research community. This was in response to the findings of a joint working party of the Institute of Materials and the Institute of Physics & Engineering in Medicine. The UKSB is the democratic Society for the whole biomaterials community.

Irish Stem Cell FoundationIrish Stem Cell Foundation

The Irish Stem Cell Foundation is an independent, non-profit medical research charity. Established in October 2009, it is composed of researchers, clinicians, patients advocates, patients, science communicators, bioethicists, lawyers, teachers, and studen ts.
          

  
Global Institute of Stem Cell Therapy and Research 

GIOSTAR is a coalition of esteemed and illustrious scientific minds in the field of stem cell science, genetics and cancer research. GIOSTAR Chairman Dr. Anand Srivastva is credited for starting and establishing the field of stem cell science at the top universities of U.S.A. For over 15 years, GIOSTAR team of scientists and clinicians have been involved in the development and utilization of stem cell based clinical protocols related to stem cell transplants.   

 
BioPeople

Biopeople is Denmark’s Life Science Cluster. We are located at the University of Copenhagen, acting as a neutral catalyst for collaboration between private enterprise and public research. Biopeople is co-founded by the Ministry of Higher Education and Science. Our cluster partnership comprises all major public and private research and educational institutions, a large number of private companies plus the Danish Medicines Agency. We create inspiring meeting places, facilitate cross-disciplinary collaboration and stimulate innovation.


To support 3rd Annual Bioprocessing of Advanced Therapies Congress, contact amit.shelke@marketsandmarkets.com

                                         

Venue

3rd Annual Bioprocessing of Advanced Cellular Therapies Congress will be held at the Dorint Hotels and Resorts

Dorint Hotels and Resorts
Main Taunus Zentrum
Frankfurt, Germany

Hotel Booking Link

Accommodation is currently available at the Dorint Hotels and Resorts at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

About the Hotel

The Dorint Hotels & Resorts invite you to enjoy a relaxing, exciting, pampered, sporting and active holiday in the most attractive regions of Germany and Switzerland – on your own, as a couple or with the whole family. Whether our conference hotels in central location, our wellness hotels to enjoy and relax or our holiday apartments at the sea or in the countryside – you'll make a find at the Dorint Hotels & Resorts.

For further information, please contact:

Email: events@marketsandmarkets.com 

 
Copyright 2017 by MarketsandMarkets Research Private Ltd. All Rights Reserved.

Contact Us : events@marketsandmarkets.com